Pre-Emptive Kidney Retransplantation from Deceased Donors
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- McDonald, S.P.; Russ, G.R. Survival of cadaveric kidney transplants compared with those reciving dialysis treatment in Australia and New Zealand 1991–2001. Nephrol. Dial. Transplant 2002, 17, 2212–2219. [Google Scholar] [CrossRef] [PubMed]
- Wolfe, R.A.; Ashby, V.B.; Milford, E.L.; Ojo, A.O.; Ettenger, R.E.; Agodoa, L.Y.; Held, P.J.; Port, F.K. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 1999, 341, 1725–1730. [Google Scholar] [CrossRef] [PubMed]
- Cattran, D.C.; Fenton, S.S.A. Contemporary management of renal failure: Outcome of the failed allograft recipient. Kidney Int. 1993, 43 (Suppl. S41), S36–S39. [Google Scholar]
- Franco, A.; Mas, P.; Gonzalez, Y.; Andres, A.; Zarraga, S.; Esforzado, N.; Alonso, A.; Gonzalez, F.; Hernandez, D.; Beneyto, I. There are 33,784 functioning kidney grafts in Spain. Who monitors them and how? Transplant Proc. 2021, 53, 2672–2674. [Google Scholar] [CrossRef] [PubMed]
- USRDS. USRDS 2008 anual data report: Atlas of end stage renal disease in the United States national Institute of diabetes and digestive and kidney diseases: Bethedsa. Natl. Inst. Odf Health 2008, 147. [Google Scholar]
- Johnston, O.; Rose, C.L.; Gill, J.S.; Gill, J.S. Risks and Benefits of Preemptive Second Kidney Transplantation. Transplantation 2013, 95, 705–710. [Google Scholar] [CrossRef]
- Girerd, S.; Girerd, N.; Duarte, K.; Giral, M.; Legendre, C.; Mourad, G.; Garrigue, V.; Morelon, E.; Buron, F.; Kamar, N.; et al. Preemptive second kidney transplantation is associated with better graft survival compared with non-preemptive second transplantation: A multicenter French 2000-2014 cohort study. Transpl. Int. 2017, 31, 408–423. [Google Scholar] [CrossRef]
- Florit, E.A.; Bennis, S.; Rodríguez, E.; Revuelta, I.; De Souza, E.; Esforzado, N.; Cofan, F.; Ricart, M.J.; Torregrosa, J.B.; Campistol, J.M.; et al. Pre-emtivere transplantation in patients with chronic kidney graft failure. Transplant. Proc. 2015, 47, 2351–2353. [Google Scholar] [CrossRef]
- Girerd, S.; Girerd, N.; Aarnink, A.; Solimando, E.; Ladrière, M.; Kennel, A.; Rossignol, P.; Kessler, M.; Frimat, L. Temporal trend and time-varying effect of preemptive second kidney transplantation on graft survival: A 30-year single-center cohort study. Transplant. Proc. 2016, 48, 2663–2668. [Google Scholar] [CrossRef]
- Papalois, V.E.; Moss, A.; Gillingham, K.J.; Sutherland, D.E.R.; Matas, A.J.; Humar, A. PRE-emptive transplants for patients with renal failure. Transplantation 2000, 70, 625–631. [Google Scholar] [CrossRef]
- Prezelin-Reydit, M.; Combe, C.; Harambat, J.; Jacquelinet, C.; Merville, P.; Couzi, L.; Leffondré, K. Prolonged dialysis duration is associated with graft failure and mortality after kidney transplantation: Results from the French transplant data base. Nephrol. Dial. Transplant. 2019, 34, 538–545. [Google Scholar] [CrossRef]
- A Milton, C.; Russ, G.R.; Mcdonald, S.P. Pre-emptive renal transplantation from living donors in Australia: Effect on allograft and patient survival. Nephrology 2008, 13, 535–540. [Google Scholar] [CrossRef] [PubMed]
- Franco, A.; Más-Serrano, P.; González, Y.; Balibrea, N.; Rodríguez, D.; López, M.I.; Contreras, F.J.P. Una aproximación al trasplante renal anticipado de donante cadáver. Estudio de cohortes emparejadas. Nefrologia 2020, 40, 32–37. [Google Scholar] [CrossRef]
- Meier-Kriesche, H.-U.; Kaplan, B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes. Transplantation 2002, 74, 1377–1381. [Google Scholar] [CrossRef] [PubMed]
- Wong, G.; Chua, S.; Chadban, S.J.; Clayton, P.; Pilmore, H.; Hughes, P.D.; Ferrari, P.; Lim, W.H. Waiting time between failure of first graft and second kidney transplant and graft and patient survival. Transplantation 2016, 100, 1767–1775. [Google Scholar] [CrossRef]
- Gill, J.S. Mananging patients with a failer kidney transplant: How can we do better? Curr. Opin. Nephrol. Hipertens. 2011, 20, 616. [Google Scholar] [CrossRef]
- López Gómez, J.M.; Pérez Flores, Y.; Jofre, R.; Carretero, D.; Rodríguez-Benitez, P.; Villaverde, M.; Pérez-García, R.; Nassar, G.M.; Niembro, E.; Ayus, J.C. Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance. J. Am. Soc. Nephrol. 2004, 15, 2494–2501. [Google Scholar] [CrossRef]
- Mourad, G.; Minguet, J.; Pernin, V.; Garrigue, V.; Peraldi, M.-N.; Kessler, M.; Jacquelinet, C.; Couchoud, C.; Duny, Y.; Daurès, J.-P. Similar patient survival following kidney allograft failure compared with non-transplanted patients. Kidney Int. 2014, 86, 191–198. [Google Scholar] [CrossRef]
- Gregoor, P.S.; Zietse, R.; Van Saase, J.; De Hoek, C.O.; Ijzermans, J.; Lavrijssen, A.; De Jong, G.; Kramer, P.; Weimar, W. Immunosuppression should be stopped in patients with renal allograft failure. Clin. Transplant. 2001, 15, 397–401. [Google Scholar] [CrossRef]
- Augustine, J.J.; Woodside, K.J.; Padiyar, A.; Sanchez, E.Q.; Hricik, D.E.; Schulak, J.A. Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure. Transplantation 2012, 94, 738–743. [Google Scholar] [CrossRef] [PubMed]
- Goldfarb-Rumyantzev, A.S.; Hurdle, J.F.; Baird, B.C.; Stoddard, G.; Wang, Z.; Scandling, J.D.; Barenbaum, L.L.; Cheung, A.K. The role of pre-emptive re-transplant in graft and recipient outcome. Nephrol. Dial. Transplant. 2006, 21, 1355–1364. [Google Scholar] [CrossRef] [PubMed]
- Arnol, M.; Prather, J.C.; Mittalhenkle, A.; Barry, J.M.; Norman, D.J. Long-term kidney regraft survival from deceased donors: Risk factors and outcomes in a single center. Transplantation 2008, 86, 1084–1089. [Google Scholar] [CrossRef] [PubMed]
- Altieri, P.; Sau, G.; Cao, R.; Barracca, A.; Menneas, A.; Micchittu, B.; Cabiddu, G.; Esposito, P.; Pani, A. Immunosuppressive treatment in dialysis patients. Nephrol. Dial. Transplant. 2002, 17 (Suppl. S8), S2–S9. [Google Scholar] [CrossRef] [PubMed]
- Kiberd, B.A.; Belistsky, P. The fate of failed renal transplant. Transplantation 1995, 59, 645–647. [Google Scholar] [CrossRef] [PubMed]
- Perl, J.; Zhang, J.; Gillespie, B.; Wikström, B.; Fort, J.; Hasegawa, T.; Fuller, D.S.; Pisoni, R.L.; Robinson, B.M.; Tentori, F. Reduced survival and quality of life following return to dialysis after transplant failure: The Dialysis Outcomes and Practice Patterns Study. Nephrol. Dial. Transplant. 2012, 27, 4464–4472. [Google Scholar] [CrossRef]
- Akman, B.; Özdemir, F.; Sezer, S.; Miçozkadioǧlu, H.; Haberal, M. Depression levels before and after renal transplantation. Transplant. Proc. 2004, 36, 111–113. [Google Scholar] [CrossRef]
Dialysis | Pre-Dialysis | p | |
---|---|---|---|
Donor age (years) | 53.0 (49.0–57.5) | 57.6 (53.5–61.8) | 0.122 |
Donor gender (m/w) | 21/15 (58.3/41.7%) | 25/11 (69.3/30.7%) | 0.635 |
Recipient age (at second transplant) (years) | 52.3 (48.4–56.1) | 58.2 (54.3–62.1) | 0.037 |
Recipient gender (m/w) | 21/15 (58.3/41.7%) | 20/16 (55.5/44.5%) | 0.267 |
Blood group | 0.6604 | ||
| 16 (43.3%) | 18 (50.0%) | |
| 1 (3.3%) | 1 (3.3%) | |
| 0 (0.0%) | 3 (8.3%) | |
| 19 (53.4%) | 14 (39.4%) | |
First graft survival (months) | 88.6.0 (1.0–145.5) | 138.5 (80.3–173.5) | 0.047 |
Waiting list time (months) | 5.0 (2.8–11.5) | 2.0 (0.88–4.0) | 0.002 |
Cold ischemia (hours) | 17.0 (15.0–21.0) | 16.5 (13.8–18.3) | 0.309 |
Follow-up period (months) | 32.0 (14.8–45.8) | 29.5 (15.0–47.8) | 0.767 |
HLA antibodies | |||
| 16 (44.4%) | 11 (30.6%) | 0.330 |
| 13 (36.1%) | 13 (36.1%) | 1.000 |
| 18 (50.0%) | 14 (38.9%) | 0.477 |
HLA mismatch | 1.000 | ||
| 9 (25.0%) | 8 (22.2%) | |
| 27 (75.0%) | 28 (77.8%) | |
Rituximab | 12 (33.3%) | 5 (13.9%) | 0.099 |
Thymoglobulin | 35 (97.2%) | 32 (88.9%) | 0.353 |
Tacrolimus | 36 (100%) | 34 (94.4%) | 0.472 |
m-TOR inhibitor | 23 (63.9%) | 26 (72.2%) | 0.613 |
Micophenolate | 13 (36.1%) | 10 (27.7%) | 0.791 |
Dialysis | Pre-Dialysis | p | |
---|---|---|---|
Early loss | 2 (5.6%) | 0 (0.0%) | 0.473 |
Delayed renal function | 5 (16.7%) | 1 (3.3%) | 0.195 |
Acute rejection | 2 (5.6%) | 3 (8.3%) | 1.000 |
Final serum creatinine (mg/dL) (median) | 1.50 (1.20–2.20) | 1.50 (1.2–2.2) | 0.950 |
Final CKD Epi (mL/mn) | 43.9 (17.7–78.8) | 44.2 (13.8–90.0) | 0.963 |
Albumin/creatinine ratio (mg/g) (median) | 37.0 (13–87) | 80 (21–204) | 0.190 |
Mean recipient survival time (95% CI) (months) | 97 (69–124) | 131 (94–168) | 0.707 |
Mean graft survival time (95% CI) (months) | 74 (47–102) | 131 (94–168) | 0.052 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Franco Esteve, A.; Mas-Serrano, P.; Marco, F.M.; Garin Cascales, E.; Perez Contreras, F.J. Pre-Emptive Kidney Retransplantation from Deceased Donors. Transplantology 2024, 5, 37-45. https://doi.org/10.3390/transplantology5010004
Franco Esteve A, Mas-Serrano P, Marco FM, Garin Cascales E, Perez Contreras FJ. Pre-Emptive Kidney Retransplantation from Deceased Donors. Transplantology. 2024; 5(1):37-45. https://doi.org/10.3390/transplantology5010004
Chicago/Turabian StyleFranco Esteve, Antonio, Patricio Mas-Serrano, Fransico Manuel Marco, Eduardo Garin Cascales, and Francisco Javier Perez Contreras. 2024. "Pre-Emptive Kidney Retransplantation from Deceased Donors" Transplantology 5, no. 1: 37-45. https://doi.org/10.3390/transplantology5010004
APA StyleFranco Esteve, A., Mas-Serrano, P., Marco, F. M., Garin Cascales, E., & Perez Contreras, F. J. (2024). Pre-Emptive Kidney Retransplantation from Deceased Donors. Transplantology, 5(1), 37-45. https://doi.org/10.3390/transplantology5010004